Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community
HER2-positive patients with ARCM receiving trastuzumab therapy had a better prognosis than HER2-positive and HER2-negative patients with ARCM not receiving trastuzumab therapy, and this trend has been increasing in the trastuzumab era. These findings highlight the importance of HER2-targeted treatments in improving prognosis for BC patients with ARCM.
Authors
- Kazuki Moro (ORCID: https://orcid.org/0000-0002-6826-4374)
- Toshifumi Wakai (ORCID: https://orcid.org/0000-0003-2443-3428)
- Takeshi Kashimura (ORCID: https://orcid.org/0000-0002-9267-1017)
- Chizuko Kanbayashi (ORCID: https://orcid.org/0000-0003-4162-4744)
- Nobuaki Sato (ORCID: https://orcid.org/0000-0002-5171-085X)
- Mitsuhiro Watanabe (ORCID: https://orcid.org/0000-0002-4500-780X)
- Mayuko Ikarashi
- Shinya Fujiki (ORCID: https://orcid.org/0000-0002-9412-1254)
- Yasuo Saijo (ORCID: https://orcid.org/0000-0003-4721-1270)
- Eiko Sakata
- Yu Koyama (ORCID: https://orcid.org/0000-0001-9743-6473)
- Chie Toshikawa
- Naoki Kubota (ORCID: https://orcid.org/0000-0002-1292-0897)
- Takayuki Inomata (ORCID: https://orcid.org/0000-0002-2199-6850)
- Yuji Okura (ORCID: https://orcid.org/0000-0003-4268-4730)
- Masato Moriyama (ORCID: https://orcid.org/0000-0002-8773-8686)
- Akira Kikuchi (ORCID: https://orcid.org/0000-0001-5438-9806)
- Keiichi Tsuchida
- Koji Kaneko
- Kazuyuki Ozaki
- Naohito Tanabe
Institutions
- Niigata University of Pharmacy and Medical and Life Sciences (JP)
- University of Niigata Prefecture (JP)
- Niigata Cancer Center Hospital (JP)
- Niigata City General Hospital (JP)
- Niigata University (JP)
Publication Details
- Journal
- Breast Cancer
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1007/s12282-024-01623-0
- Citations
- 4
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.61